- +86 0371-86658258
- info@coreychem.com
English
Purity: 99%;
Boiling point: 452.5±45.0 °C(Predicted)
Density: 1.505±0.06 g/cm ³ (Predicted)
Acidity coefficient (pKa) : 5.63±0.10(Predicted)
| Product Name | methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate |
| Synonyms | methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate;EOS-60622;Methyl2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate;Methyl2-{(1R)-1-[(2-amino-5-bromo-3-pyridinyl)oxy]ethyl}-4-fluorobenzoate;METHYL2-[(1R)-1-[(2-AMINO-5-BROMOPYRIDIN-3-YL)OXY]ETHYL]-4-FLUOROBENZOATE;Benzoicacid,2-[(1R)-1-[(2-amino-5-bromo-3-pyridinyl)oxy]ethyl]-4-fluoro-,methylester;(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoicacidmethylester;(R)-Methyl2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate |
| CAS NO | 1454848-00-0 |
| Purity | 99% |
| MF | C15H14BrFN2O3 |
| MW | 369.19 |
| Contact | selina@coreychem.com |
Methyl (R)-2-(1-((2-amino-5-bromopyridin-3-yloxy)ethyl)-4-fluorophenyl)acetate (CAS: 1454848-00-0) is a complex fluorinated aromatic compound featuring key pharmacophoric groups, including:
Fluorinated phenyl ring (enhances lipophilicity and metabolic stability)
Aminopyridine moiety (common in kinase inhibitors and CNS-active drugs)
Bromo and amino substituents (reactive sites for further functionalization)
Pharmaceutical Intermediate:
Serves as a building block in the synthesis of small-molecule drugs, potentially used in the development of kinase inhibitors, anti-inflammatory agents, or oncology-targeted therapies.
Lead Compound Development:
Used in SAR (Structure–Activity Relationship) studies for the optimization of drug candidates due to its rich functionalization and asymmetric center.
R&D Building Block:
Suitable for C–C, C–N, and amide bond formation in advanced pharmaceutical synthesis, especially in medicinal chemistry research and custom synthesis projects.
25KG/50KG/200KG per barrel; Or package according to customer needs
